 HAMILTON, Bermuda, Nov. 05, 2020 GLOBE NEWSWIRE -- Kiniksa Pharmaceuticals, Ltd. Nasdaq: KNSA Kiniksa, a biopharmaceutical company with a pipeline of assets designed to modulate immunological pathways across a spectrum of diseases, today reported third quarter 2020 financial results and highlighted recent pipeline and corporate activity. 